Bispecific Monoclonal Antibodies Market: High-Growth Biologics...

σε πρόσθεσε στο Wellness

2026-07-31 09:11:02 -

Bispecific Monoclonal Antibodies Market: High-Growth Biologics Segment Driven by Dual-Target Cancer Therapies, Complex Engineering, and a Deep Global Pipeline

The Bispecific Monoclonal Antibodies Market is one of the fastest-growing biologics segments, powered by dual-target cancer therapies, sophisticated antibody engineering, and a deep global development pipeline. The market was valued at about USD 9.1–12.7 billion in 2025–2026 and is projected to reach roughly USD 58.1 billion by 2035, at CAGRs in the 13.7–18.4% range. Some...

0 Σχόλια 0 Μοιράστηκε 101 Views 0 Προεπισκόπηση